Dmk Pharmaceuticals (DMK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DMK Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Dmk Pharmaceuticals.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent6.66
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments6.00
Accounts receivable0.00
Other Receivables0.00
Inventories0.66
Disposal Group, Including Discontinued Operation, Assets, Current AS0.01
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.54
Total Current Assets7.87
Equipment/Property/Plant Net1.08
Other Assets, Noncurrent0.01
Total Assets8.96
Liabilities
Accounts Payable, Current AC9.97
Accrued Liabilities, Current AC2.32
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.17
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.93
Total Current Liabilities13.46
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.30
Deferred Revenue, Noncurrent DE0.16
Other liabilities, Noncurrent0.00
Lease Liability Current-
Total Liabilities13.92
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.01
Additional Paid In Capital Common Stock318.18
Retained Earnings / Accumulated Deficit-323.47
Other Equity-0.33
Common Stockholder's Equity-5.62
Non-controlling interests & other0.33
Total Stockholder's Equity-5.29
Liabilities & Stockholder's Equity8.96
4 historic quarters locked

Sign in to unlock the full Dmk Pharmaceuticals balance sheet history.

About Dmk Pharmaceuticals Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001999371-23-000197

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.